CTHRC1 and cancer: In support of the aforementioned findings, a particularly aggressive pro-tumor CAF population - the collagen triple helix repeat containing 1-positive (CTHRC1+) fibroblasts - was identified: a tumor-exclusive subset whose abundance increases with cancer progression and correlates with poor patient prognosis (Lu et al., 2025).